Knowing that naloxone works by stalling the µ-opioid receptor in an early, latent state suggests that molecules that can bind more tightly or more selectively to this form of the receptor could be ...
The Food and Drug Administration is set to treat application under its priority program that seeks to accelerate the review ...
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with ...
Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...
MedPage Today on MSN
New Injectable Approved for a Type of Kidney Disease
Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...
News-Medical.Net on MSN
Monthly biologic injection improves severe asthma control and reduces steroid use
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback